SCHEMBL6295192

SCHEMBL6295192

CC(=O)O[C@H]1O[C@H](COC(=O)c2ccc(Cl)cc2)[C@@H](OC(=O)c2ccc(Cl)cc2)[C@@]1(C)OC(C)=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
UPP1 Q16831 1/20 0.44
POLB P06746 1/20 0.40
HPGD P15428 1/20 0.39
ALDH1A1 P00352 2/20 0.38
CHRNB2 P17787 1/20 0.38
CHRNA5 P30532 1/20 0.38
CHRNA7 P36544 1/20 0.38
CHRNA4 P43681 1/20 0.38
CYP2C19 P33261 2/20 0.37
CYP2D6 P10635 1/20 0.37
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
MAPT P10636 2/20 0.37
NPSR1 Q6W5P4 1/20 0.37
GLA P06280 1/20 0.35
CYP1A2 P05177 1/20 0.35
GAPDH P04406 1/20 0.35
GAA P10253 1/20 0.34
PTPN1 P18031 1/20 0.34
UBE2D3 P61077 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6291233 0.86 ALDH1A1 (0.47) UPP1POLBHPGDALDH1A1CHRNB2
SCHEMBL14364291 0.85 ALDH1A1 (0.47) POLBALDH1A1MEN1KMT2AMAPT
SCHEMBL13065489 0.85 ALDH1A1 (0.47) POLBALDH1A1MEN1KMT2AMAPT
SCHEMBL3293698 0.85 ALDH1A1 (0.47) POLBALDH1A1MEN1KMT2AMAPT
SCHEMBL3293695 0.85 ALDH1A1 (0.47) POLBALDH1A1MEN1KMT2AMAPT
SCHEMBL14377586 0.85 ALDH1A1 (0.47) POLBALDH1A1MEN1KMT2AMAPT
SCHEMBL3990202 0.80 HPGD (0.49) UPP1HPGDALDH1A1MEN1KMT2A
SCHEMBL13843285 0.80 HPGD (0.49) UPP1HPGDALDH1A1MEN1KMT2A
SCHEMBL3990198 0.80 HPGD (0.49) UPP1HPGDALDH1A1MEN1KMT2A
SCHEMBL14853799 0.79 ALDH1A1 (0.49) POLBHPGDALDH1A1CHRNB2CHRNA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6891036-B2 Process for the preparation of ribofuranose derivatives INALCO S.P.A. (IT) 2005-05-10 US claimed
US-20040158059-A1 Process for the preparation of ribofuranose derivatives INALCO S.P.A. (IT) 2004-08-12 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040158059-A1 Process for the preparation of ribofuranose derivatives RNGTT, RPIA, MRM1 UPP1 61/4885POLB 705/4885HPGD 2092/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.